Details of the Drug

General Information of Drug (ID: DMH0FMN)

Drug Name
CaPre
Indication
Disease Entry ICD 11 Status REF
Hypertriglyceridemia 5C80.1 Phase 2 [1]
Cross-matching ID
TTD ID
D0BM4T

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)